Prevention of diabetes development in those with the metabolic syndrome

被引：4

作者：

Tupper, Traci ^{[1
]}

Gopalakrishnan, Geetha ^{[1
]}

机构：

[1] Brown Univ, Warren Alpert Med Sch, Providence, RI 02860 USA

来源：

MEDICAL CLINICS OF NORTH AMERICA | 2007年 / 91卷 / 06期

关键词：

D O I：

10.1016/j.mcna.2007.06.006

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Metabolic syndrome is characterized by abnormal glucose levels, central obesity, hypertension, elevated triglycerides, and low HDL cholesterol. This article reviews available data regarding the impact of lifestyle modification and drug therapies on the progression to diabetes in high risk individuals, such as those with hypertension, dyslipidemia, obesity, and prediabetes. Lifestyle and pharmaco-logical interventions may alter metabolic parameters and impact progression to diabetes. However, the cost-effectiveness of these interventions are unclear.

引用

页码：1091 / +

页数：17

共 50 条

[21] Comparison of Rates of Progression of Coronary Atherosclerosis in Patients With Diabetes Mellitus Versus Those With the Metabolic Syndrome
Bayturan, Ozgur
Tuzcu, E. Murat
Uno, Kiyoko
Lavoie, Andrea J.
Hu, Tingfei
Shreevatsa, Ajai
Wolski, Kathy
Schoenhagen, Paul
Kapadia, Samir
Nissen, Steven E.
Nicholls, Stephen J.
AMERICAN JOURNAL OF CARDIOLOGY, 2010, 105 (12): : 1735 - 1739
[22] Coronary Artery Calcium Screening in Persons with Metabolic Syndrome and Diabetes: Implications for Prevention
Tehrani, David M.
Malik, Shaista
Wong, Nathan D.
METABOLIC SYNDROME AND RELATED DISORDERS, 2013, 11 (03) : 143 - 148
[23] Fenofibrate for Cardiovascular Disease Prevention in Metabolic Syndrome and Type 2 Diabetes Mellitus
Steiner, George
AMERICAN JOURNAL OF CARDIOLOGY, 2008, 102 (12A): : 28L - 33L
[24] Exercise for prevention and treatment of cardiovascular disease, type 2 diabetes, and metabolic syndrome
Gaesser G.A.
Current Diabetes Reports, 2007, 7 (1) : 14 - 19
[25] Atorvastatin Efficacy in the Prevention of Cardiovascular Events in Patients with Diabetes Mellitus and/or Metabolic Syndrome
Marcello Area
Drugs, 2007, 67 (Suppl 1) : 43 - 54
[26] Atorvastatin efficacy in the prevention of cardiovascular events in patients with diabetes mellitus and/or metabolic syndrome
Arca, Marcello
DRUGS, 2007, 67 : 43 - 54
[27] Studies on prevention of obesity, metabolic syndrome, diabetes, cardiovascular diseases and cancer by tea
Yang, Chung Shu
Wang, Hong
Sheridan, Zachary Paul
JOURNAL OF FOOD AND DRUG ANALYSIS, 2018, 26 (01) : 1 - 13
[28] Obesity, metabolic syndrome and diabetes mellitus after renal transplantation: Prevention and treatment
Wissing, Karl Martin
Pipeleers, Lissa
TRANSPLANTATION REVIEWS, 2014, 28 (02) : 37 - 46
[29] Metformin use in polycystic ovary syndrome: Metabolic benefits and diabetes prevention - Reply
Salpeter, Shelley R.
Buckley, Nicholas S.
Kahn, Justin A.
Salpeter, Edwin E.
AMERICAN JOURNAL OF MEDICINE, 2008, 121 (08): : E11 - E11
[30] Metabolic syndrome in the prevention of cardiovascular diseases and diabetes-still a matter of debate?
Ma, X.
Zhu, S.
EUROPEAN JOURNAL OF CLINICAL NUTRITION, 2013, 67 (05) : 518 - 521

← 1 2 3 4 5 →